Rechenberg: Thanks to Imported Drugs, America Has Lost Control of Its Medicine Cabinet

Rechenberg: Thanks to Imported Drugs, America Has Lost Control of Its Medicine Cabinet

America is facing a growing crisis in its medical system — not from a lack of talent or innovation, but from a breakdown in the control, safety and supply of essential medicine. Our growing reliance on imports is now driving serious drug shortages, destabilizing supply chains and increasingly making medications unsafe.

America’s Drug Shortage Isn’t a Supply Problem—It’s a Production Crisis

America’s Drug Shortage Isn’t a Supply Problem—It’s a Production Crisis

In the U.S. today, frontline cancer treatments are being rationed. ERs are short on sedatives. Amoxicillin—one of the most prescribed antibiotics in the country—has been in critical shortage. These are not temporary disruptions. They reflect a structural breakdown caused by the erosion of America’s pharmaceutical manufacturing base and a decades-long surge in generic drug imports.

Generic Drugs Need Government Support, House Health Subcommittee Admits

Generic Drugs Need Government Support, House Health Subcommittee Admits

U.S. based generic drug makers need government support to expand – and maybe even to survive – the onslaught of imports nearly every member of the House Energy and Commerce Committee Subcommittee on Health said in a hearing on Wednesday.

U.S. Dangerously Reliant on High-Risk Imported Drug Supply

U.S. Dangerously Reliant on High-Risk Imported Drug Supply

The American pharmaceutical supply chain has become dangerously dependent on imports and foreign-controlled supply chains. Over the past 20 years, the country has experienced a skyrocketing rate on pharmaceutical imports and increasing foreign reliance.

CPA Applauds Sen. Cotton for Introduction of the ‘PILLS Act’ – Legislation to Incentivize Domestic Production of Lifesaving Medicines

CPA Applauds Sen. Cotton for Introduction of the ‘PILLS Act’ – Legislation to Incentivize Domestic Production of Lifesaving Medicines

A smart policy like the ‘PILLS Act’ would prioritize domestic production of essential generics. It’s precisely the market signal needed to attract serious investment and rebuild the industry at home.

CPA Calls on JPMorgan and Bank of America to Withdraw from CATL IPO

CPA Calls on JPMorgan and Bank of America to Withdraw from CATL IPO

The IPO, widely seen as the first major test of President Trump’s America First Investment Policy (AFIP), directly undermines the President’s February directive to block U.S. investment in companies linked to the Chinese military, human rights abuses, and authoritarian surveillance state.